by Biolexis | Sep 27, 2022 | News & Media
September 21-22, 2022 Biolexis Therapeutics Business Development Director Kyle Medley participated in RESI Conference (Redefining Early-Stage Investments), Boston, MA on Sep 21-22, 2022. https://resiconference.com/
by Biolexis | Apr 13, 2022 | News & Media
April 8-13, 2022 BioLexis is pleased to announce the acceptance of a poster presentation at the American Association for Cancer Research (AACR) Annual Meeting, taking place at the Ernest N. Morial Convention Center in New Orleans from April 8-13, 2022. Representing...